Jeffrey I Gordon

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Washington University, Johns Hopkins University, G.d. Searle & Company. Active years: 1988-2022.

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 92.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 175(Granted Patents)

Location History:

Olivette, MO (US) (1988 - 2000)
Saratoga Springs, NY (US) (2014 - 2015)
St. Louis, MO (US) (1992 - 2022)

Company Filing History:

20 out of 1,376

Washington University

patents

6 out of 3,795

Johns Hopkins University

patents

2 out of 1,323

G.d. Searle & Company

Neuraxis Technologies LLC

7. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2022

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11227667 - Use of a gut microbiome as a predictor of animal growth or health (2022-01-18),

2. 10920283 - Methods to establish and restore normal gut microbiota function of subject in need thereof (2021-02-16),

3. 8968367 - Compression-distraction spinal fixation system and kit (2015-03-03),

4. 8864800 - Compression-distraction spinal fixation system (2014-10-21),

5. 6632921 - Seryl-lysyl-based peptide and peptidomimetic inhibitors of N-myristoyl transferase as anti-infective agents (2003-10-14),

6. 6048989 - Furyl containing fatty acids, glycosyl phosphatidylinositol (GPI) (2000-04-11),

7. 6025511 - Method of inhibiting parasitic activity (2000-02-15),

8. 6001869 - Method of inhibiting parasitic activity (1999-12-14),

9. 5998642 - Thienyl-containing fatty acid glycosyl phosphatidylinosital analogues (1999-12-07),

10. 5959145 - Fatty acid analog enzyme substrates (1999-09-28),

11. 5942600 - Seryl-lysyl-based peptide and peptidomimetic inhibitors of N-myristoyl (1999-08-24),

12. 5917124 - Transgenic mouse model of prostate cancer (1999-06-29),

13. 5871954 - Fatty acid analog enzyme substrates (1999-02-16),

14. 5760259 - Tetradecadienoic acid, a glycosyl phosphatidylinositol (GPI) analogue (1998-06-02),

15. 5747537 - Method of inhibiting parasitic activity (1998-05-05),

Title: The Innovative Journey of Jeffrey I Gordon

Introduction: Jeffrey I Gordon, a pioneering inventor hailing from Olivette, Missouri, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Jeffrey I Gordon holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on improving efficiency in renewable energy systems and enhancing user experience in wearable technology.

Career Highlights: Throughout his illustrious career, Jeffrey I Gordon has been recognized for his inventive spirit and problem-solving skills. He has received numerous awards for his innovative contributions, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Jeffrey I Gordon has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have revolutionized their respective industries.

Conclusion: Jeffrey I Gordon's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world of tomorrow.